Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice
Keywords:
Adenosine/analogs & derivatives
Fibrosis/drug therapy
Liver Diseases/genetics
Liver Diseases/pathology
P-Glycoproteins/genetics
Thionucleosides/administration & dosage
Publisher:
Public Library of Science
Citation:
Latasa MU, Gil-Puig C, Fernandez-Barrena MG, Rodriguez-Ortigosa CM, Banales JM, Urtasun R, et al. Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice. PLoS One 2010 Dec 29;5(12):e15690.
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.